Coronary artery revascularisation: selecting the appropriate strategy

M R Adams1

  • 1Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. mark.adams@email.cs.nsw.gov.au

Internal Medicine Journal
|January 18, 2013
PubMed

Insights

Drug-eluting stents improve percutaneous coronary revascularization, reducing the need for bypass surgery. Optimal patient outcomes require collaboration between interventional cardiologists and cardiac surgeons for complex revascularization strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Drug-eluting stents have significantly advanced interventional cardiology.
  • Percutaneous coronary revascularization is now a viable option for most patients.

Purpose of the Study:

  • To examine the impact of interventional cardiology advancements on revascularization strategies.
  • To highlight the importance of choosing the appropriate revascularization method.
  • To emphasize the need for collaboration between cardiac surgeons and interventional cardiologists.

Main Methods:

  • Review of current interventional cardiology practices.
  • Analysis of drug-eluting stent efficacy and safety data.
  • Comparative assessment of percutaneous coronary revascularization versus coronary bypass surgery.

Main Results:

  • Interventional cardiology advancements have increased the practicality of percutaneous coronary revascularization.
  • The focus has shifted towards appropriate stent use and complex strategy selection.
  • Collaboration is identified as crucial for optimal patient outcomes.

Conclusions:

  • Interventional cardiology has made percutaneous coronary revascularization a primary option.
  • Choosing the right revascularization strategy requires careful consideration.
  • Collaboration between cardiac surgeons and interventional cardiologists is essential for best outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
419
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346